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To generate meaningful information, translational research must employ paradigms that
allow extrapolation from animal models to humans. However, few studies have evaluated
translational paradigms on the basis of defined validation criteria. We outline three
criteria for validating translational paradigms. We then evaluate the Hebb–Williams maze
paradigm (Hebb and Williams, 1946; Rabinovitch and Rosvold, 1951) on the basis of
these criteria using Fragile X syndrome (FXS) as model disease. We focused on this
paradigm because it allows direct comparison of humans and animals on tasks that
are behaviorally equivalent (criterion #1) and because it measures spatial information
processing, a cognitive domain for which FXS individuals and mice show impairments as
compared to controls (criterion #2). We directly compared the performance of affected
humans and mice across different experimental conditions and measures of behavior
to identify which conditions produce comparable patterns of results in both species.
Species differences were negligible for Mazes 2, 4, and 5 irrespective of the presence of
visual cues, suggesting that these mazes could be used to measure spatial learning in
both species. With regards to performance on the first trial, which reflects visuo-spatial
problem solving, Mazes 5 and 9 without visual cues produced the most consistent
results. We conclude that the Hebb–Williams mazes paradigm has the potential to
be utilized in translational research to measure comparable cognitive functions in FXS
humans and animals (criterion #3).
Keywords: Fragile X syndrome, human, mouse, spatial learning, Hebb–Williams maze, translational research
INTRODUCTION
“By carefully selecting tasks for animals with high construct validity to human tasks, reliability and
accuracy of translational efforts will not be lost and meaningful progress can be made in ameliorating
the cognitive deficits that affect the lives of those suffering from mental illness.”
(Gilmour et al., 2013, p. 2126).
The quotation above articulates the potential benefits of translational research for society and
stresses the need to carefully select tasks that allow extrapolation from animal models to humans in
order to reap these benefits. Surprisingly, there is little consensus on what criteria should be used
for validating translational paradigms, a fact that significantly hinders selection of appropriate tasks
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(see Willner, 1986 for validation criteria for animal models)
and therefore limits the likelihood that laboratory research will
translate to human treatments. We address this limitation by
outlining three criteria for validating translational paradigms.
We then use these criteria to evaluate the Hebb–Williams maze
paradigm using Fragile X syndrome (FXS) as a model disease.
Fragile X syndrome is the most common identifiable genetic
cause of intellectual disability and a leading genetic cause of
autism spectrum disorder (ASD) (e.g., Hagerman, 1987; Farzin
et al., 2006). The disorder arises from mutation of a single gene,
the FMR1 (Fragile X Mental Retardation 1) gene, which codes for
a protein that plays a key role in experience-dependent synaptic
plasticity (e.g., Huber et al., 2002). The mutation is caused by
intergenerational expansion of a trinucleotide region upstream
of the coding sequence results in methylation and silencing
of the FMR1 gene [Online Mendelian Inheritance in Man R©
(OMIM) 3095501; Verkerk et al., 1991]. The silencing of the
FMR1 gene results in several significant behavioral and cognitive
impairments including deficits in attention (Backes et al., 2002;
Baumgardner et al., 1995), visual-spatial cognition (Crowe
and Hay, 1990; Cornish et al., 1998, 1999), working memory
(Schapiro et al., 1995; Jakala et al., 1997), and visual-perceptual
processing (Kogan et al., 2004a). Because it is the outcome of
a single gene defect, FXS offers a remarkable opportunity to
investigate the validity and feasibility of translational paradigms
by comparing the animal model with affected individuals.
The animal model for the disease, the fmr1 knock-out (KO)
mouse, has significantly contributed to our understanding of the
neurobiology and synaptic mechanisms of the disorder and to the
identification of potential therapeutic agents (e.g., Berry-Kravis
et al., 2011). Despite these advances, translation of drug discovery
research from the mouse model to humans has proven difficult
(e.g., Arbaclofen trial: Berry-Kravis et al., 2017), highlighting the
need for the identification of valid translational tasks.
Drawing from the literature (Willner, 1986; Gilmour et al.,
2013; McGonigle and Ruggeri, 2014; Gabel et al., 2016), we
propose that to allow for appropriate extrapolation from animal
to human studies, translational paradigms must: (1) allow direct
comparison of humans and animals on tasks that are behaviorally
equivalent, (2) measure constructs that are fundamental to
the disorder, and (3) engage comparable underlying neural
mechanisms and cognitive functions in both species2. To our
knowledge, only three studies have directly compared the
performance of FXS humans and KO mouse on behaviorally
equivalent paradigms (Frankland et al., 2004; Koekkoek et al.,
2005; MacLeod et al., 2010; see, e.g., Gilmour et al., 2013; Gabel
et al., 2016 for other conditions). Two studies (Frankland et al.,
2004; Koekkoek et al., 2005) employed paradigms that measure
prepulse inhibition, a function that is thought to be impaired in
1http://www.ncbi.nlm.nih.gov/omim
2Note that criterion #3 is derived from Willner (1986) and Sjoberg (2017). While
Willner’s discussion of validity focuses on the cognitive processes that underlie
psychopathology (e.g., memory, perception, motivation, etc.), Sjoberg extends
the discussion to include underlying biological mechanisms. While both are
relevant and important in FXS, the present study, which was conducted from an
experimental psychology perspective, focuses on the cognitive functions measured
by the Hebb–Williams paradigm, namely visuo-spatial abilities.
FXS as indicated by heightened sensitivity to sensory stimulation
(mouse: Chen and Toth, 2001; humans: Miller et al., 1999).
The other study employed a paradigm that measures spatial
processing (MacLeod et al., 2010), a central feature of cognitive
impairment in affected individuals (e.g., Crowe and Hay, 1990;
Cornish et al., 1998, 1999; Kogan et al., 2004a) and the murine
model (e.g., Baker et al., 2010; Gandhi et al., 2014b, but see Fisch
et al., 1999). We review their findings below.
Frankland et al. (2004) measured prepulse inhibition to
acoustic startle in fmr1 KO mice, affected individuals and
their respective comparison groups. Whereas prepulse inhibition
was enhanced in KO mice as compared to controls, it was
significantly reduced in humans. The authors concluded that
the FMR1/fmr1 gene impacts sensory processing in both species.
However, because the results were opposite in direction for
mice as compared to humans, it is unclear whether different
mechanisms might be measured by this paradigm across the two
species. Koekkoek et al. (2005) used an eye blink reflex paradigm
to measure prepulse inhibition. They report a comparable
reduction in prepulse inhibition in FXS humans and KO
mice as compared to their respective comparison groups. This
eye blink reflex paradigm has also been used in translational
research to successfully demonstrate efficacy of a metabotropic
glutamate receptor antagonist (i.e., Fenobam) for reversing
prepulse inhibition in affected humans (Berry-Kravis et al., 2009).
While these results point to the utility of the eye blink paradigm
for translational research, it measures a discrete sensorimotor
gating function that provides limited insight in to the central
cognitive impairments in FXS.
MacLeod et al. (2010) used the Hebb–Williams mazes
paradigm to measure visuo-spatial abilities in fmr1 KO mice,
affected individuals, and their respective comparison groups.
Hebb–Williams mazes require successful navigation through
different mazes whose configurations can be varied to provide
problems of varying difficulty (Rabinovitch and Rosvold, 1951;
Meunier et al., 1986). MacLeod et al. (2010) employed this
paradigm because both traditional animal-based and computer
versions of the task exist, allowing researchers to test mice
and humans under equivalent conditions (Shore et al., 2001).
Moreover, performance on the mazes appears to be dependent
on the integrity of brain areas with known impairment in
FXS humans and KO mice. Lesion studies in mice have
demonstrated that successful performance on paradigms such
as the radial arm maze, T-maze, and water maze rely on intact
hippocampal processing (Mitchell et al., 1982; Morris et al.,
1982; Hock and Bunsey, 1998; Okada and Okaichi, 2009).
Equivalent results are found with similar visuo-spatial tasks
in humans (Rogers and Kesner, 2006; Hunsaker et al., 2008).
Structural abnormalities of the hippocampus are seen in FXS
patients (see Bostrom et al., 2016 for a review). Although
similar gross morphological differences have not been observed
in the Fmr1 KO mice, significant neuronal pathology has been
described in the form of longer dendritic spines in pyramidal
cells in subfield CA1 (Grossman et al., 2006), smaller intra-infra
pyramidal mossy fiber terminal fields (Mineur et al., 2002), as
well as shorter dendrites, fewer dendritic spines and functional
synaptic connections (Braun and Segal, 2000). Studies of human
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hippocampal neuronal dysmorphology reveal a higher density
of dendritic spines suggestive of abnormal synaptic pruning
in FXS (Irwin et al., 2000). Another area involved in maze
performance is the posterior parietal cortex. This area is recruited
during spatial navigational tasks in humans (Hyvarinen and
Poranen, 1974; Andersen and Buneo, 2002; Spiers and Maguire,
2007) and mice (Harvey et al., 2012). Kogan et al. (2004b)
demonstrated that visual-spatial processing associated with the
posterior parietal cortex is selectively impaired in humans with
FXS. Finally, the paradigm assesses cognitive functions that are
related to the clinical features of the disorder and that are the
principle targets for interventions. MacLeod et al. (2010) found
comparable impairments on the mazes for both KO mice and
affected humans which manifested as a lack of improvement
in performance across trials, indicative of a spatial learning
deficit. At the molecular level, Gandhi et al. (2014a) showed
that a metabotropic glutamate receptor antagonist (i.e., MPEP)
reversed these deficits in KO mice.
These findings suggest that the Hebb–Williams paradigm
meets two of the criteria for validating translational paradigms:
it allows for direct comparison of humans and animals on a
paradigm that is behaviorally equivalent (criterion #1), and it
measures cognitive functions and underlying neural mechanisms
that are fundamental to the disorder (criterion #2). In addition,
unlike other cognitive tasks, the Hebb–Williams maze paradigm
is not too difficult for individuals with FXS to complete nor
does it produce unacceptable levels of variability (Berry-Kravis
et al., 2006). In the present study, we evaluated whether the
paradigm meets criterion #3, with an emphasis on whether the
paradigm engage comparable underlying cognitive functions in
both species. We directly compared the performance of FXS
humans and KO mice across different experimental conditions
and measures of behavior. Our goal was to identify which
conditions, if any, yield similar performance and hence which
conditions might be used to measure comparable underlying
cognitive functions in both species. This direct comparison
approach complements the homology of impairments approach
(Sjoberg, 2017) adopted by the aforementioned studies where
mutant mice were compared to wild-type controls and FXS
individuals were compared to typically developing participants
or those matched for intellectual ability. While the homology
of impairments approach provides valuable information for
the identification of key features of the disorder, it is less
appropriate for identifying tasks that engage comparable
underlying mechanisms across species. Indeed, this approach
assumes that reduced performance of affected participants
compared to controls on equivalent tasks reflects impairments
in the same underlying mechanism(s) in humans and animals
(Sjoberg, 2017). This assumption might not always be valid for
the following reasons. First, there are difficulties inherent to
matching comparison groups to participants affected by FXS.
Human studies typically match on the basis of chronological age
or intellectual ability (e.g., Frankland et al., 2004; Kogan et al.,
2004a, 2009; Lightbody et al., 2006; MacLeod et al., 2010; Klusek
et al., 2015; McDuffie et al., 2015). Such techniques limit test
implementation and interpretation of group effects. For example,
choosing chronological age matched comparisons might yield
ceiling effects for the unaffected group or floor effects in the
FXS group. Moreover, impairments in the FXS group might
be better explained by differences in understanding instructions
rather than an impairment in the cognitive function of interest.
On the other hand, similarities and/or differences between
FXS individuals and mental-age matched comparisons, who
are typically younger, might be better explained by differences
in their stage of development rather than serve as evidence
for preservation or impairment in a specific cognitive domain.
Similarly, in mouse studies, there is no universal methodology
for matching the comparison group to the KO group on the
basis of intellectual abilities. Instead, behavior of KO mice is
typically compared to that of age-matched wild type littermates,
making it impossible to determine whether group differences
arise from general cognitive impairments or from impairment
of a distinct cognitive function. Second, the neuroconstructivist
view of development (reviewed by Karmiloff-Smith, 1998, 2009)
suggests that when there are no differences in performance
in special populations vs. typically developing individuals, one
cannot necessarily conclude that cognitive function is normal
in the special population because the two groups may rely on
different underlying mechanisms to perform the task. Differences
in underlying mechanisms may arise because alterations at the
level of gene expression (e.g., see Kooy, 2003; Errijgers and
Kooy, 2004) could compensate for perturbations in the course of
development such that affected individuals demonstrate normal
or near normal performance at the behavioral level. It is also
possible that affected individuals compensate by employing
different neuronal structures to achieve the same outcome
as typically developing individuals. Such considerations limit
inferences that can be drawn on the basis of the homology of
impairments approach, especially with respect to the measure of
equivalent underlying mechanisms in humans and animals.
In the present study, we adopted a direct comparison
approach to address these limitations. Indeed, to be informative
and ultimately predictive of therapeutic response, translational
paradigms should measure the same underlying construct across
species (Willner, 1986; Gilmour et al., 2013). While there
is no perfect solution, introducing a procedural modification
or new variable to a paradigm with the goal of examining
whether both species react similarly to this modification provides
compelling evidence that equivalent underlying mechanisms are
being measured (Willner, 1986; Shore et al., 2001; van der Staay
et al., 2010; Sjoberg, 2017). This approach circumvents some
of the limitations associated with the homology of impairments
approach. It is important to note that we conceptualize these
two approaches as complementary in yielding evidence in favor
of the validity of a specific translational paradigm. We do not
question the valuable contribution made by studies adopting
the homology of impairments approach but instead highlight
limitations of this approach to advancing the field of translational
research. An optimal outcome is one whereby a behaviorally
equivalent paradigm is first shown to measure key features of the
disease by yielding homologous performance differences between
comparison and affected participants across species, followed by
a direct comparison of humans and animals on variations of the
paradigm to identify conditions yielding comparable patterns of
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performance, which would suggest that the paradigm taps into
comparable underlying mechanisms.
Having already established the potential for the Hebb–
Williams mazes to serve as a translational paradigm using a
homology of impairments approach (MacLeod et al., 2010),
we sought complementary evidence in the present study using
a direct comparison approach. We compared the profile of
performance of FXS participants with that of KO mice on
two variants of the Hebb–Williams paradigm and on multiple
measures of performance. We compared data obtained on the
standard version of the paradigm (MacLeod et al., 2010) as
well as new data obtained on a variation with visual cues.
We also performed multiple new analyses to directly compare
humans and mice on various indicators of cognitive function and
performance. Performing multiple cross-species comparisons
across experimental conditions and measures (Vorhees and
Williams, 2014) allowed us to identify which conditions, if any,
produce comparable patterns of performance across species. As
such, the present study seeks to identify which conditions of
the paradigm meet all of the validation criteria outlined herein
by accruing new data with respect to criterion three. This study
therefore seeks to validate the Hebb–Williams maze paradigm for
use in translational and drug discovery research and to provide
practical information regarding which conditions and measures
offer the best potential for extrapolating from mice to humans.
Notwithstanding the variable nomenclature and experimental
manipulations that have been used to describe and investigate
the impact of visual cues on spatial learning, evidence from
both animals and humans suggest that the presence of visual
cues in maze environments improves learning in typically
developing participants (Heft, 1979; Jansen-Osmann and Fuchs,
2006; Waller and Lippa, 2007; reviewed by Chan et al., 2012).
However, in certain populations visual cues may be ignored
rather than being used to assist navigation (Wilkniss et al.,
1997; Moffat and Resnick, 2002; Hanlon et al., 2006; Robaey
et al., 2016). Particularly relevant to FXS, Robaey et al. (2016)
showed that children who exhibit symptoms of Attention Deficit
Hyperactivity Disorder (ADHD) do not rely on visual cues
while navigating in an eight-arm radial maze. Because a majority
of males with Fragile X exhibit symptoms of ADHD (e.g.,
Hagerman, 1987; Hatton et al., 2002; Farzin et al., 2006; Sullivan
et al., 2006), introducing visual cues to the Hebb–Williams
paradigm provides a critical experimental variation upon which
to compare humans and mice. We also conducted new analyses to
determine whether the two species display comparable patterns
of results for the two main processes involved in solving mazes,
namely basic visual functioning necessary for solving a novel
spatial task and learning/memory. Indeed, while performance on
the first trial is thought to reflect visuo-spatial processing and
problem solving (Hebb and Williams, 1946), performance on
subsequent trials reflects memory for the configuration of the
maze and goal location as indicated by rate of learning across
trials. Finally, we examined the relative difficulty of the mazes
across the two species (Meunier et al., 1986). Level of difficulty is
an index of problem-solving complexity and comparable patterns
would suggest similar approaches to maze problem-solving in
both species.
MATERIALS AND METHODS
Mice
Two groups of male FVB.129P2-Fmr1tm1Cgr/J mice (JAX Stock
#004624) mice were obtained from Jackson Laboratories (Bar
Harbor, Maine, United States). The first group of mice provided
data which has not been previously published on the paradigm
with visual cues. The second group corresponds to mice tested
in MacLeod et al. (2010) on the standard paradigm. Each strain
had been backcrossed for 11 generations. Mice are pigmented
(gray), do not carry the rd1 mutation and possess the wild type
Pde6b allele indicating that they do not suffer from blindness
due to retinal degeneration. For the standard group, 11 animals
were shipped at 4 weeks of age and were tested when they were
approximately 3 months old. For the visual cue group, which was
tested a year after the standard group, 10 animals were tested
when they were approximately 5 months old. Eight days prior
to behavioral testing, all subjects were individually housed in
a climate-controlled vivarium (20–22◦C) that was maintained
on a 12 h light-dark cycle with lights on from 0700 to 1900.
All testing was conducted during the light phase of the cycle.
Mice were fed Harlan Global Rodent Chow and tap water. They
were maintained at 85–90% of their ad lib body weight. Mice
were weighed daily and fed their individually weighed ration
of food 30 min after completion of the session. The mice were
treated in accordance with the guidelines and principles set
by the Canadian Council on Animal Care and tested under a
protocol approved by the University of Ottawa Animal Care
Committee.
Mouse Apparatus
Mice were tested using the Hebb–Williams maze apparatus
as described by Meunier et al. (1986). The apparatus was
constructed using black opaque Plexiglas and was covered with a
clear Plexiglas top (Plastics of Ottawa Ltd., Ottawa, ON, Canada).
It consisted of a square open field (60 cm × 60 cm × 10 cm)
with start and goal box compartments (20 cm× 10 cm× 10 cm)
located at diagonally opposite corners. These compartments were
fitted with clear Plexiglas lids that were attached with hinges and
could be blocked with removable clear Plexiglas barriers. The goal
box was fitted with a ledge (8 cm × 2.5 cm) with a recessed food
cup in the center (2.5 cm diameter). The floor of the maze was
divided into 36-equal squares that were clearly outlined in white.
The squares were used as markers for placing the barriers in
different maze configurations and to define error zones. The same
maze configurations as in MacLeod et al. (2010) were employed,
namely mazes 2, 4, 5, 8, 9, 11, and 12 (Rabinovitch and Rosvold,
1951). Testing was in the following order: Maze 12, 2, 8, 4, 5, 9,
and 11. Pilot data with humans from our laboratory suggested
that the other mazes were too easy and might yield ceiling effects.
The order was determined on the basis of maze difficulty (less to
more difficult) as assessed using pilot data. Removable barriers
(10 cm high) were created using black opaque Plexiglas and
each was supported by two permanent bases (2.5 cm × 2.5 cm).
Extra-maze cues were minimized by conducting the study in an
all-black enclosure and by having a dim light as the only source
of illumination.
Frontiers in Molecular Neuroscience | www.frontiersin.org 4 March 2018 | Volume 11 | Article 99
fnmol-11-00099 March 26, 2018 Time: 15:31 # 5
Boutet et al. Hebb–Williams Maze Paradigm and Fragile-X Syndrome
For the visual cue group, six images of simple geometric
shapes (e.g., circle, square, and triangle) surrounded by a white
background were added to each of the mazes (10 cm× 10 cm). An
identical set of six shapes was used in each maze configuration.
Each set of shapes was the same color as that of the test maze with
the white background clearly distinguishing the shape from the
maze wall. The visual cues were distributed within a test maze
such that at least one image was visible from any position within
the maze. Visual cues were laminated and adhered to the interior
of the maze with double-sided tape.
Mouse Procedure
The protocol consisted of three consecutive phases: habituation,
acquisition, and testing. Initially, mice were habituated to the
maze environment for 20 min per day on 4 consecutive days
with barriers and doors to the start and goal box removed.
During the last two sessions the goal box was baited (Rodent
Chow, 100 mg) and mice had ad lib access to the food for the
duration of the session. Subsequently, mice from both groups
were trained on six acquisition mazes without visual cues as
described by Rabinovitch and Rosvold (1951) (Figure 1a). On
any given day, mice were tested such that they completed
five trials for each of two of the six acquisition mazes. Mice
completed all six acquisition mazes in sequence as many times
as necessary for them to attain the criterion performance, which
was defined as two consecutive sessions completed successfully
in less than 30 s each. The acquisition phase required an average
of 7 days to complete. On each acquisition trial, mice received a
small reinforcer (Rodent Chow, 20 mg). Immediately following
acquisition, mice were given a selection of the standard test
mazes over 4 days (Rabinovitch and Rosvold, 1951) according
to the same training protocol used during acquisition sessions.
None of the acquisition or testing sessions exceeded 180 s.
Mice completed the Rabinovitch and Rosvold (1951) maze
configurations. Latency and number of errors were recorded.
Latency was recorded from the moment the barrier at the start
box was removed until the animal took its first bite of food. An
error was scored each time the animal’s two front paws crossed
into an error zone (Figure 1b). Experimenters were blind to the
animal genotypes and were never visible to the mice during the
runs. The maze was thoroughly cleaned between trials and all
trials were recorded using a closed-circuit camera mounted on
the ceiling directly above the maze.
Human Participants
Twenty-six participants were recruited from patient contact lists
at Rush University Medical Center, Chicago, IL, United States.
Participants either completed the mazes with visual cues (n= 10,
mean chronological age = 22 years, SD = 3.84, mean verbal
mental age = 6.26 years, SD = 3.02) or without visual cues
(n = 15, mean chronological age = 24 years, SD = 4.9, mean
verbal mental age = 7.57 years, SD = 1.29). The first group
of participants provided data, which has not been previously
published, on the paradigm with visual cues. The second group
corresponds to participants tested in MacLeod et al. (2010) on
the standard paradigm. All had a DNA-confirmed diagnosis of
FXS. Informed consent was obtained from caregivers and assent
was obtained from the individuals with FXS. All participants
were paid $25 per hour for their participation in the study and
were treated in accordance to the ethical principles established
FIGURE 1 | Maze configurations. (a) Testing was conducted using the six practice mazes (A–F) and (b) the seven test mazes depicted. For each maze
configuration, the (S) depicted in the bottom right hand corner represents the start box, and the (F) in the top left corner represents the goal box. Error zones are
depicted by the dotted lines. Location of visual cues is depicted by geometric shapes. Reprinted in part from MacLeod et al. (2010). A comparative study of the
performance of individuals with Fragile X syndrome and Fmr1 knockout mice on Hebb–Williams mazes. Genes, Brain and Behavior, 9(1), 53–64.
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by the Research Ethics Board at the University of Ottawa. Both
the ethics committees of the School of Psychology, University
of Ottawa, and of the Rush University Medical Center approved
the study. Written informed consent was obtained from carers of
the participants. Participants also provided their written assent to
participate in the study.
Human Measures
A brief Medical History Questionnaire was administered to
all caregivers of participants to screen for any problems that
would exclude them from the study. Exclusion criteria were
any significant health or vision difficulties (e.g., color blindness,
amblyopia, astigmatism, etc.) that would impact controlling a
joystick or viewing the maze stimuli. Four FXS participants were
excluded from the study because they did not complete at least
half of the mazes. These participants reported and exhibited
symptoms of anxiety and appeared distracted throughout the
administration.
Human Apparatus
All participants were tested using a version of the virtual Hebb–
Williams maze designed by Shore et al. (2001). Five mazes
were eliminated from the original Hebb–Williams set for the
purpose of this project because our pilot studies indicated that
participants found these mazes too easy. In order to reduce
administration time, a factor that is particularly important when
testing participants affected by intellectual disability, only the
most challenging mazes were used. All participants were tested
on the remaining subset of mazes.
Experiments were performed on an Asus PC with a 19-inch
Acer LCD monitor. Mazes were displayed at a resolution of
640 × 480 in full-screen mode. Participants navigated through
the virtual environment at a constant velocity of 12 km/hr
(forward, backward) and a turn rate of 50 degrees per second (left,
right) using a Logitech Attack 3 joystick. Assuming a viewing
height of 5 ft 6 in., the projection of the whole maze appeared
to participants as 20 m2, and the diagonal straight line from start
to finish was perceived as being located at a distance of 28.3 m.
Each maze was made up of a 6 × 6 room, with a 1 × 1
alcove at the entrance (start area) and exit (goal area) of the maze.
Walls were created using textured rectangles that differed in color
depending on the maze configuration. A different color was used
for each maze configuration to indicate to participants that a
new maze was being presented. The start alcove and the floors
were textured with black and gray marble effect. Each wall of the
goal alcove was white and contained the image of a comic book
character to provide motivation and reward for the participants.
The roof was textured using beige and brown mottled square tiles
(Figure 2). For the visual cue group, the Hebb–Williams virtual
maze was identical to that used in the standard condition, with
the exception of the addition of visual cues. For each test maze,
six images of simple geometric shapes (e.g., circle, square, and
triangle) surrounded by a white background were added to the
maze environment (10 cm× 10 cm). Geometric shapes were used
because of they are easy to recognize and discriminate across age
ranges. An identical set of six shapes was placed in each maze
configuration. Each set was the same color as that of the test maze
FIGURE 2 | (A) Schematic illustration of virtual Hebb–Williams Maze #12.
Arrows indicate the location and point of view of the navigator. Letters on the
arrow correspond to the points of view illustrated in B, C, and E. An error was
scored each time the participant crossed the threshold illustrated by the
broken lines. (B) Scene from the start box of the maze without (B1) and with
visual cues (B2, visible visual cue is a green 5-pointed star). (C) Scene
illustrating a choice point leading to an error zone or to the correct escape
path. (D) Scene illustrating an error zone (indicated by the red asterisk here
and in A). (E) Scene illustrating the goal box.
with the white background clearly distinguishing the shape from
the maze wall (Figure 1b). Visual cue placement was the same as
was used for the mouse apparatus.
Human Procedure
All participants were individually tested by a research assistant,
in a quiet room without their caregivers present. The tasks
were administered during a 1–1.5 h session and presented in a
standardized order as described above. Participants were trained
on two types of practice mazes. An alley maze was presented first
and enabled participants to establish how to adaptively maneuver
through the virtual environment, while maintaining direct visual
contact with the goal area. After meeting this criterion, a T-maze
was presented in which participants had to choose a virtual
navigational pathway in order to practice searching for the
goal area of the maze. Visual cues were not provided during
practice. Criterion was achieved in both acquisition mazes when
participants could complete three consecutive maze trials in less
than 30 s each. At any time if a participant exceeded 120 s
during a trial, the trial was considered finished and the participant
proceeded to the next maze. For both the acquisition and testing
mazes, participants received a sticker as reward after each trial,
and after completing all three trials of a maze they received a small
piece of candy to be saved and consumed after the experiment was
terminated.
After the acquisition sessions, human participants completed
three trials of each test maze (Figure 1b). In between testing
for each maze, participants were provided with a 2-min break,
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at which time a children’s DVD was played. After completing
the fourth maze (#8) all participants were given a 10-min
break. Latency for solving the maze (time taken from the maze
entrance to exit) and number of errors (number of times a
participant crossed a predefined error line – see Figure 1b) were
calculated.
Statistical Analyses
Because of floor effects and large variability across participants
for both error and latency, data from Maze 11, the last maze
tested, is excluded from this study. Outliers were removed from
the data such that any score that was more than 2.5 SD away
from the group mean was replaced by the next lowest or highest
score that is within 2.5 SD of the mean. Because error and
latency measures did not appear to meet the assumption of
normality upon visual inspection, both measures were square
root transformed.
Inverse Efficiency
Inverse efficiency allows for direct cross-species comparisons
within the same statistical analysis (Shore et al., 2001). Moreover,
inverse efficiency is the most appropriate measure for cross-
species comparisons because humans and mice can adopt
different strategies with respect to speed vs. accuracy to solve
a maze (Shore et al., 2001). It is calculated by standardizing
raw latency and raw error scores into Z-scores using the overall
grand means and standard deviations from all subjects of the
same species. Performance inverse efficiency scores were also
calculated as follows: Z(Latency) + Z(Error)/2. Larger inverse
efficiency scores indicate relatively poorer maze performance.
This composite measure weights increases in latency and error
equally and therefore accounts for differences between species
in the relative contribution of errors and latency to overall
performance (Shore et al., 2001).
Rate of Learning
To compare learning and memory across Species and
Condition, we calculated a rate of learning measure using
individual difference scores on inverse efficiency as follows:
[(T1 − T2) + (T2 − T3)]/2. A positive value indicates that
efficiency increased across trials.
Difficulty
Two indices of difficulty were computed: one for learning and
one for performance on the first trial. For learning, difficulty was
computed using the method described in Meunier et al. (1986).
We examined the relative difficulty of each Maze for humans
and mice and the Standard and With Visual Cue conditions
separately. A difficulty index (D) was calculated as follows:
mean number of errors across trials/number of error zones. The
number of error zones were determined according to Rabinovitch
and Rosvold (1951). We also computed an index of difficulty
for performance on the first trial by modifying the computation
proposed by Meunier et al. (1986). Difficulty was calculated as
follows: mean number of errors for the first trial/number of error
zones.
Analysis of Variance (ANOVAs)
All statistical analyses were conducted using SPSS. To examine
the influence of adding a Visual Cue, a 2 × 2 × 6 × 3 mixed-
design ANOVA was conducted on latency, error, and inverse
efficiency with Species (Humans, Mice) and Condition (Standard,
Visual Cue) as independent-groups variables and Maze (2, 4,
5, 8, 12, and 9) and Trial (1, 2, and 3) as repeated-measures
variables. Note that whereas mice were tested on five trials,
human participants were tested on three trials to cater to the
limited attention span of affected individuals. To allow direct
comparison of the two species within the same analysis, only
trials one, two, and three were used from the mouse data. We
did not analyze trials 4 and 5 because these additional trials
may have engendered some additional fatigue/practice that might
affect learning and that was not experienced by the human
participants. Results are shown in Tables 1–3. The rate of learning
variable was submitted to a 2 × 2 × 6 mixed-design ANOVA
with Species (Humans, Mice) and Condition (Standard, Visual
Cue) as independent-groups variables and Maze (2, 4, 5, 8, 9,
and 12) as repeated-measures variable. Finally, we examined
performance on Trial 1 only to compare the two species on
visuo-spatial processing performance. A 2 × 6 mixed-design
ANOVA with Species (Humans, Mice) as independent groups
variable and Maze (2, 4, 5, 8, 12, and 9) as repeated-measures
variable was conducted on the inverse efficiency measure for
the Standard and Visual Cue conditions separately (Table 4).
Because Maulchy’s test of sphericity was significant for most
conditions, we applied the Greenhouse-Geisser correction to all
effects involving repeated-measures factors.
TABLE 1 | Analysis of variance (ANOVA) of latency between factors Species
(humans and mice), Condition (standard and visual cues), Maze (2, 4, 5, 8, 9, and
12), and Trials (1, 2, and 3).
Test of between-subjects effects df F η2p p
Species 1 189.22 0.82 0.00
Visual Cue 1 1.12 0.03 0.30
Species ∗ Visual Cue 1 4.89 0.10 0.03
Error 43
Trial 1.98 10.95 0.20 0.00
Trial ∗ Species 1.98 1.08 0.02 0.34
Trial ∗ Visual Cue 1.98 0.96 0.02 0.39
Trial ∗ Species ∗ Visual Cue 1.98 0.11 0.00 0.89
Error (Trial) 85.23
Maze 3.76 24.49 0.36 0.00
Maze ∗ Species 3.76 10.06 0.19 0.00
Maze ∗ Visual Cue 3.76 3.44 0.07 0.01
Maze ∗ Species ∗ Visual Cue 3.76 3.37 0.07 0.01
Error (Maze) 161.52
Trial ∗ Maze 7.54 1.19 0.03 0.31
Trial ∗ Maze ∗ Species 7.54 2.64 0.06 0.01
Trial ∗ Maze ∗ Visual Cue 7.54 0.39 0.01 0.92
Trial ∗ Maze ∗ Species ∗ Visual Cue 7.54 1.01 0.02 0.43
Error (Trial ∗ Maze) 324.16
df, degress of freedom; F, F statistic; η2p, partial eta squared; p, probability of a
Type I error.
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TABLE 2 | Analysis of variance (ANOVA) of errors between factors Species
(humans and mice), Condition (standard and visual cues), Maze (2, 4, 5, 8, 9, and
12), and Trials (1, 2, and 3).
Test of between-subjects effects df F η2p p
Species 1 1.39 0.03 0.25
Visual Cue 1 1.01 0.02 0.32
Species ∗ Visual Cue 1 0.00 0.00 0.97
Error 41
Maze 3.84 36.10 0.47 0.00
Maze ∗ Species 3.84 15.77 0.28 0.00
Maze ∗ Visual Cue 3.84 2.10 0.05 0.09
Maze ∗ Species ∗ Visual Cue 3.84 0.77 0.02 0.54
Error (Maze) 157.37
Trial 1.97 13.25 0.24 0.00
Trial ∗ Species 1.97 0.43 0.01 0.65
Trial ∗ Visual Cue 1.97 0.07 0.00 0.93
Trial ∗ Species ∗ Visual Cue 1.97 1.35 0.03 0.27
Error (Trial) 80.64
Maze ∗ Trial 7.32 1.07 0.03 0.39
Maze ∗ Trial ∗ Species 7.32 2.87 0.07 0.01
Maze ∗ Trial ∗ Visual Cue 7.32 0.50 0.01 0.84
Maze ∗ Trial ∗ Species ∗ Visual Cue 7.32 1.05 0.03 0.40
Error (Maze∗Trial) 300.07
df, degress of freedom; F, F statistic; η2p, partial eta squared; p, probability of a
Type I error.
TABLE 3 | Analysis of variance (ANOVA) of inverse efficiency between factors
Species (humans and mice), Condition (standard and visual cues), Maze (2, 4, 5,
8, 9, and 12), and Trials (1, 2, and 3).
Test of between-subjects effects df F η2p p
Species 1 0.12 0.00 0.73
Visual Cue 1 4.05 0.09 0.05
Species ∗ Visual Cue 1 5.09 0.11 0.03
Error 41
Maze 3.11 36.30 0.47 0.00
Maze ∗ Species 3.11 13.43 0.25 0.00
Maze ∗ Visual Cue 3.11 4.83 0.11 0.00
Maze ∗ Species ∗ Visual Cue 3.11 3.73 0.08 0.01
Error (Maze) 127.59
Trial 1.90 15.69 0.28 0.00
Trial ∗ Species 1.90 1.91 0.04 0.16
Trial ∗ Visual Cue 1.90 1.36 0.03 0.26
Trial ∗ Species ∗ Visual Cue 1.90 0.89 0.02 0.41
Error (Trial) 78.02
Maze ∗ Trial 5.90 1.77 0.04 0.11
Maze ∗ Trial ∗ Species 5.90 4.34 0.10 0.00
Maze ∗ Trial ∗ Visual Cue 5.90 0.47 0.01 0.83
Maze ∗ Trial ∗ Species ∗ Visual Cue 5.90 1.17 0.03 0.32
Error (Maze∗Trial) 241.78
df, degress of freedom; F, F statistic; η2p, partial eta squared; p, probability of a
Type I error.
Alpha adjustment was not performed because is was deemed
too conservative on the grounds that a valid paradigm is likely
to yield non-significant differences between species and because
TABLE 4 | Analysis of variance (ANOVA) of rate of learning between factors
Species (humans and mice), Condition (standard and visual cues), Maze (2, 4, 5,
8, 9, and 12).
df F η2p p
Species 1 3.10 0.07 0.09
Visual Cue 1 1.73 0.04 0.20
Species ∗ Visual Cue 1 0.30 0.01 0.59
Error 41
Maze 4.08 2.35 0.05 0.06
Maze ∗ Species 4.08 2.32 0.05 0.06
Maze ∗ Visual Cue 4.08 0.70 0.02 0.59
Maze ∗ Species ∗ Visual Cue 4.08 0.84 0.02 0.50
Error (Maze) 167.18
df, degress of freedom; F, F statistic; η2p, partial eta squared; p, probability of a
Type I error.
of the potentially large number of mean comparisons following
significant interactions. Instead, we focused on effect sizes for
comparing relevant means operationalized as follows: no effect:
Cohen’s d of 0.0–0.2; small effect: Cohen’s d of 0.2–0.5; medium
effect: Cohen’s d of 0.5–0.8; large effect: Cohen’s d of 0.8 and more.
RESULTS
Latency
As expected, the main effect of Trial was significant with latency
decreasing from Trial 1 (M = 5.13; SE = 0.12) to Trial 2
(M= 4.75; SE= 0.13) to Trial 3 (M= 4.53; SE= 0.11), indicating
that learning occurred whereby participants took progressively
less time to complete a maze from Trial 1 to Trial 3. We focus
on effects involving a Species × Condition interaction since
significant findings involving this interaction suggest that the
two species react differently to the presence of visual cues. The
Species × Condition × Maze interaction was significant. For
humans, comparing the Standard Condition to the Visual Cue
Condition for each maze, participants took less time to find the
goal with the Visual Cue for mazes 4 (d = −0.4), 5 (d = −0.6),
and 9 (d = −0.7). Participants took more time to find the goal
with the Visual Cue for mazes 8 (d = 0.2), 12 (d = 0.3). There
was no effect of Visual Cue for maze 2 (d = 0.0). Mice took more
time finding the goal with the Visual Cue for mazes 4 (d = 0.3),
5 (d = 0.4), 8 (d = 0.4), and 9 (d = 0.7). There was no effect of
Visual Cue for mazes 2 (d = 0.0) and 12 (d = 0.1). Hence, there
was consistency between the two species only for Maze 2 where
the Visual Cue did not improve the speed at which the maze was
solved for both humans and mice.
Errors
As expected, the main effect of Trial was significant with number
of errors decreasing from Trial 1 (M = 1.65; SE= 0.06) to Trial 2
(M= 1.43; SE= 0.05) to Trial 3 (M= 1.31; SE= 0.05), indicating
that learning occurred whereby participants made progressively
fewer errors from Trial 1 to Trial 3. The Species × Condition
Interaction was not significant, nor were any of the interactions
involving the Species × Condition effect. The main effect of
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Condition was not significant. These results suggest that both
species reacted similarly to the Visual Cue whereby adding a
Visual Cue did not influence errors committed while solving the
maze for both humans and mice.
Inverse Efficiency
Results are illustrated in Figure 3. As expected the main effect
of Trial was significant with efficiency increasing from Trial 1
(M = 0.20; SE = 0.05), to Trial 2 (M = −0.02; SE = 0.05),
to Trial 3 (M = −0.15; SE = 0.05), indicating again that
learning occurred whereby participants became progressively
more efficient at solving the mazes from Trial 1 to Trial 3. This
improvement in performance is best captured by the Rate of
Learning analyses presented below. The Species × Condition
Interaction was significant. The Species × Condition × Maze
interaction was also significant. For humans, comparing the
Standard Condition to the Visual Cue Condition for each maze,
performance was more efficient with the Visual Cue for Maze
2 (d = −0.2), 4 (d = −0.7), 5 (d = −0.5), and 9 (d = −1.0).
Performance was less efficient with the Visual Cue for Mazes
12 (d = 0.2), and there was no effect of Condition for maze 8
(d = 0.1). For mice, performance was more efficient with the
Visual Cue for Mazes 12 (d = −0.8), 2 (d = −0.6), 4 (d = −0.4),
5 (d = −0.2). Performance was less efficient with Visual Cue for
Maze 8 (d = 0.8) and 9 (d = 0.8). Hence, for both species, the
addition of a visual cue improved efficiency for mazes 2, 4, 5 but
not for the other mazes.
Considering that comparing the Standard with the Visual
Cue conditions yielded inconsistent results, we also compared
humans and mice on each maze for the Standard and Visual
Cue conditions separately. For the Standard condition, Maze
4 (d = 0.4), Maze 5 (d = 0.0), Maze 9 (d = 0.0), and Maze
12 (d = −0.4) yielded no or small species differences. Maze 2
(d=−1.4) and Maze 8 (d=−1) yielded large species differences.
For the Visual Cue condition, only Maze 12 (d = 0.2) yielded
a small species difference. The differences between humans and
mice were large for Maze 2 (d = −0.7), Maze 4 (d = 1.3),
Maze 5 (d = 0.7), Maze 8 (d = −2.2), and Maze 9 (d = 0.7).
Hence, performance was generally consistent across species for
the Standard condition but not for the Visual Cue condition.
For performance on the first trial only, we report findings with
respect to the Species variable only. For the Standard Condition,
the main effect of Species was significant [F(1,24) = 4.28,
p = 0.05, η2p = 0.15]. The Maze × Species interaction was
also significant [F(3.65,87.33) = 2.77, p = 0.04, η2p = 0.10]. For
the Visual Cue Condition, the main effect of Species was not
significant [F(1,24) < 1]. The Maze × Species interaction was
significant [F(2.88,48.96)= 8.17, p< 0.01, η2p = 0.33]. To explore
FIGURE 3 | Mean inverse efficiency and standard-errors for both humans (black) and mice (gray) in the standard Hebb–Williams maze paradigm (A) and in the
condition with visual cues (B). Larger inverse efficiency scores indicate less efficient maze-solving performance.
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these significant interactions, we compared humans and mice on
each maze for the Standard and Visual Cue conditions separately.
For the Standard condition, Maze 5 (d = 0.4) and Maze 9
(d = −0.2) yielded small species differences. Maze 4 (d = 0.7)
and Maze 12 (d = −0.7) yielded medium species differences.
Maze 2 (d = −1.7) and Maze 8 (d = −2.7) yielded large species
differences. For the Visual Cue condition, Maze 9 (d = 0.6)
yielded medium species differences. All other mazes yielded large
species differences (Maze 2: d = −0.8; Maze 4: d = 1.1; Maze
5: d = 0.9; Maze 8: d = −4.4; Maze 12: d = 0.8). These results
suggest that performance obtained on Mazes 5 and 9 of the
standard paradigm provide the best measure of visuo-spatial
processing and problem solving across species.
Rate of Learning
Rate of Learning indicates the amount by which efficiency
increased across trials. Results are illustrated in Figure 4.
The Species × Condition interaction was not significant. The
Species × Condition × Maze interaction was significant. For
humans, comparing the Standard Condition to the Visual Cue
Condition for each maze, rate of learning was superior with the
Visual Cue for Maze 4 (d = −0.4), Maze 5 (d = −0.3), Maze 8
(d = −0.3), Maze 9 (d = −0.2), and Maze 12 (d = −0.6). Rate of
learning was inferior with the Visual Cue for Maze 2 (d = 0.2).
For mice, rate of learning was superior with the Visual Cue for
Maze 12 (d=−0.2). Rate of learning was inferior with the Visual
Cue for Mazes 8 (d = 0.2), 4 (d = 1), and 9 (d = 0.2). There
was no effect of Condition for Mazes 2 (d = 0.1) and 5 (d = 0.1).
Except for Maze 12 for the humans and Maze 4 for the mice, effect
sizes were generally small in both species, suggesting that adding
a Visual Cue had very little impact on Rate of Learning for both
humans and mice.
We also compared humans and mice on each maze for the
Standard and Visual Cue conditions separately. For the Standard
condition Maze 2 (d = 0.04), Maze 4 (d = 0.02) and Maze 5
(d= 0.00), Maze 9 (d=−0.17) and Maze 12 (d=−0.28), yielded
no or small species differences. Differences between humans and
mice were medium for Maze 8 (d = −0.77). For the Visual Cue
condition, Maze 2 (d = −0.42), Maze 4 (d = −0.17), Maze 5
(d =−0.01), and Maze 9 (d =−0.28) yielded no or small species
differences. Differences between humans and mice were large for
Maze 8 (d=−1.02) and Maze 12 (d= 1.15). Hence, performance
was generally consistent across species for both the Standard and
the Visual Cue condition for three out of the six mazes tested (2,
4, and 5).
Difficulty
Difficulty was computed for each maze for humans and mice
and for the standard and the visual cue conditions separately
for performance across trials and for performance on the first
trial. Mazes were then ordered in ascending levels of difficulty
to examine similarities/differences in the pattern of performance
across the two species. For performance across trials (Table 5),
while patterns of difficulty were not identical across species some
consistencies were observed. Mazes 2 and 4 were among the three
easiest mazes and Mazes 5 and 12 were among the three hardest
mazes for both humans and mice. Moreover, for each species,
mazes 5, 9, and 12 were most difficult and mazes 2, 4, and 8, were
easiest irrespective the presence of visual cues. For performance
on the first trial (Table 6), Mazes 2 and 4 were among the three
FIGURE 4 | Mean rate of learning and standard-errors for both humans (white) and mice (gray) in the standard Hebb–Williams maze paradigm (A) and in the
condition with visual cues (B). A positive value indicates that participants became more efficient at solving the maze from trials 1 to 2 and from trials 2 to 3
(averaged). A value of zero indicates no learning.
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TABLE 5 | Relative difficulty (D) of the different mazes across trials for the
Standard and Visual Cue conditions for Humans and Mice separately.
Humans Mice
Standard Cue Standard Cue
Maze D Maze D Maze D Maze D
2 0.21 2 0.27 4 0.26 4 0.34
8 0.41 8 0.48 9 0.52 9 0.38
4 0.44 4 0.66 2 0.58 2 0.57
9 0.61 12 0.73 5 0.9 8 0.81
5 1.08 9 0.91 12 1.1 5 0.92
12 1.12 5 1.34 8 1.23 12 1.67
Results are presented in ascending order with the higher the D index, the more
difficult the maze. Details are provided in the text.
easiest and Maze 5 was among the three most difficult for both
species irrespective of visual cues.
Activity Level in Mice
Previous studies suggest that FXS KO mice may exhibit
increased activity levels as compared to wild type mice (e.g.,
Mineur et al., 2002). Thus, we assessed activity levels by
obtaining a count of the number of line crosses per unit
of time for trial 1 of maze 12. The latter maze was chosen
because it has the least number of partitions thus allowing
for the clearest observation of locomotion. We restricted
our analysis to trial 1 because performance on this trial is
independent of learning and memory and reflects exploratory
behavior. An independent samples t-test revealed no significant
differences in activity levels between the group tested in
the standard paradigm and the group tested with visual
cues.
DISCUSSION
Using FXS as a model disease, we examined the potential utility
of the Hebb–Williams maze paradigm (Hebb and Williams,
1946; Rabinovitch and Rosvold, 1951) for translational and
drug discovery research on the basis of three validation
criteria. The paradigm allows direct comparison of humans
and animals on tasks that are behaviorally equivalent (criterion
#1) (Shore et al., 2001; see also Gabel et al., 2016) and
measures visuo-spatial abilities, a cognitive domain for which
FXS individuals and KO mice show impairments as compared
to their respective control groups (condition #2) (e.g., Crowe
and Hay, 1990; Cornish et al., 1998, 1999; Kogan et al., 2004a).
We compared the performance of affected humans and mice
across multiple conditions and measures to evaluate whether
the paradigm engages comparable cognitive mechanisms in
both species (criterion #3). These cross-species comparisons
allowed us to identify which conditions, if any, produce
comparable patterns of performance across species and therefore
offer the best potential for extrapolating results from mice
to humans (Willner, 1986; Shore et al., 2001; van der Staay
TABLE 6 | Relative difficulty (D) of the different mazes for performance on the first
trial for the Standard and Visual Cue conditions for Humans and Mice separately.
Humans Mice
Standard Cue Standard Cue
Maze D Maze D Maze D Maze D
4 0.00 2 0.28 4 0.35 4 0.41
2 0.29 8 0.47 2 0.62 2 0.61
8 0.38 4 0.86 9 0.87 12 0.75
9 0.94 12 1.44 5 0.91 5 0.75
5 1.27 5 1.67 8 1.29 9 1.00
12 1.47 9 1.68 12 2.00 8 2.15
Results are presented in ascending order with the higher the D index, the more
difficult the maze. Details are provided in the text.
et al., 2010; Sjoberg, 2017). The discussion of our results
focuses on measures of performance that allow direct cross-
species comparisons, namely efficiency, rate of learning, and
difficulty.
We compared performance of FXS humans and KO mice
on the standard paradigm as well as on a variation of the
paradigm where visual cues were added to the mazes. Our
goal was to examine whether this variable has a comparable
impact on humans and mice, which would provide support for
the notion that the paradigm taps into comparable underlying
cognitive mechanisms in both species (Willner, 1986; Shore
et al., 2001; van der Staay et al., 2010; Sjoberg, 2017). Our
results provide mixed evidence regarding the influence of this
manipulation. Specifically, the addition of a visual cue improved
performance efficiency for both species for three out of six
mazes (i.e., 2, 4, and 5). In contrast, rate of learning was
enhanced by the presence of visual cues for both species
for only one maze (i.e., 12). Finally, looking at the human
and mice data separately, we find that relative maze difficult
was comparable with and without the presence of visual
cues, either for difficulty in learning the maze across trials,
or for performance on the first trial. Taken together, these
results suggest that visual cues do not consistently improve
spatial information processing in FXS with the exception of
specific mazes where results were consistent across species
(information pertaining to specific mazes is presented below).
While visual cues have been shown to improve spatial learning
performance in typically developing human adults and mice
(reviewed by Chan et al., 2012), this is not the case for
other populations. Consistent with our findings, there is
evidence that visual cues do not improve spatial learning in
individuals with ADHD (Robaey et al., 2016), a diagnosis
that is commonly comorbid with FXS (Sullivan et al., 2006).
FXS is also highly co-morbid with ASD (Hatton et al., 2006)
and in this population, the literature on the influence of
visual cues on spatial learning is inconclusive, in part because
comparisons are often made between conditions that differ with
respect to many variables (reviewed by Smith, 2015). Looking
at the general effect of landmarks on navigation performance,
and seemingly in agreement with our findings, it appears
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that impairments in navigation are not diminished by the
presence of visual cues in participants with ASD (Lind et al.,
2013).
Because there is considerable variation in nomenclature and
interpretation of results involving visual cues, it is difficult
to provide a simple cohesive interpretation of our findings.
The presence of visual cues is thought to shift the strategies
implicated in solving mazes from spatial learning toward
response-based learning (e.g., Packard and McGaugh, 1996).
Response-based strategies rely on reinforcement of stimulus-
response contingencies, allowing participants to solve mazes by
learning that they can reach the goal by making a specific body
turn at a choice point in the maze. Because humans affected
by FXS have been shown to display perseverative behaviors
(Van Dam et al., 2000; Kogan et al., 2009), and because we
used the same cues across mazes, it is possible that learning of
stimulus-response contingencies in the earlier mazes interfered
with learning new stimulus-response contingencies in the later
mazes, which would have rendered the visual cues ineffective
with time. To explore this possibility, we conducted separate
analyses to examine Species × Condition interactions for the
first maze tested and for the last maze tested on inverse
efficiency. In partial agreement with this interpretation, the
interaction was not significant for the first maze but approached
significance for the last maze (first maze: F = 0.827, p = 0.368,
ns; last maze: F = 3.702, p = 0.061). However, inspection
of Figure 4 suggests that rate of learning was not linked to
testing order for either condition. Another possible explanation
for our results is that participants may have had difficulty
discriminating between cues that provided information about
relative position and those that could be used for a turning
response. Indeed, while the visual cues were informative because
they were fixed and therefore could indicate to the participant
their location in the maze, they were not all located at decision
points in the mazes. Additional studies are needed to resolve
these discrepancies and to confirm under which conditions
visual cues should be used in this paradigm for cross-species
extrapolation. Future research should include probe trials where
visual cues are removed after a maze has been solved to
determine whether they contributed to improvements across
trials (e.g., Moffat and Resnick, 2002; Vorhees and Williams,
2014). Moreover, distinct visual cues should be used across
different mazes to avoid the possibility of perseveration of
responding to similar cues from one maze to the next. Finally,
because there is lower reliance on the visual modality for
navigation in mice (Brown and Wong, 2007), it would be
interesting to examine whether using cues that are optimal for
each species (e.g., olfactory in mice, visual in humans) at decision
points in a maze generates more comparable findings across
species3.
3Using different navigational cues across species might have implications for
criterion #1. However, one must consider all criteria when making methodological
decisions in translational research. If presenting each specie with tasks that
are more ecologically relevant leads to the measurement of more comparable
underlying functions (criterion 3), than we would consider this more important
than using tasks that are identical across species (see Willner, 1986, for a discussion
of face vs. construct validity in animal models).
It should be noted that humans and mice displayed more
consistent results with respect to the influence of visual
cues for measures that incorporate errors (error, inverse
efficiency, rate of learning) than for the measure of latency.
Pollard and Lysons (1969) have suggested that measures based
on errors are more indicative of learning and memory, whereas
those based on time are more indicative of exploratory and
motivational factors. Hence, it is possible that humans and mice
reacted similarly to visual cues with respect to learning as indexed
by measures of error, but not with respect some of the other
behaviors triggered by the maze environment (i.e., those indexed
by latency, including efficiency). Gandhi et al. (2014a) also found
that it was the measure of errors that was sensitive to the effects
of the mGluR antagonist MPEP, which concomitantly reversed
the deficits in PSD-95 reactivity to Hebb–Williams maze learning.
These data suggest that future studies focusing on molecular
pathways mediated by FMRP (Fragile × Mental Retardation
protein) and involved in synaptic plasticity should include errors
as a dependent variable to evaluate the effect of pharmacological,
genetic, or other manipulations.
Cross-species comparisons revealed comparable patterns of
performance for FXS humans and mice for some mazes but
not others. Focusing on the measure of efficiency, which reflects
overall performance on the mazes by combining error rates and
latency, four mazes (4, 5, 9, and 12) produced consistent results
in humans and mice in the standard condition and one maze
(12) in the visual cue condition. For rate of learning, which
reflects improvements in performance across trials, three out
of the six mazes tested (i.e., 2, 4, and 5) produced consistent
results for humans and mice for both conditions. We also
conducted cross-species comparisons by measuring the level of
difficulty of each maze for each species and each condition
separately. The relative difficulty of four mazes (2, 4, 5, and
12) was consistent in humans and mice, irrespective of the
presence of visual cues. Finally, we compared efficiency and
difficulty across species and for each condition separately for
performance on the first trial only. This allowed us to distinguish
the effects of learning/memory across trials from the ability to
utilize visual information to solve a novel spatial task on the first
trial (Hebb and Williams, 1946). Only two mazes (i.e., 5 and 9)
tested in the standard condition yielded comparable results for
humans and mice. These two mazes also produced consistent
results in humans and mice in terms of difficulty for the visual
cue condition. At the time of this writing, we retrieved only
two studies that have directly compared humans and mice on
the Hebb–Williams maze paradigm (Shore et al., 2001; Gabel
et al., 2016). These studies also report heterogeneous cross-
species consistencies across mazes tested in typically developing
participants. Shore et al. (2001) report consistent efficiency
and rate of learning for three mazes (6, 8, and 12), however,
statistical results for these group comparisons are not provided.
Gabel et al. (2016) report consistent efficiency and rate of
learning for all mazes tested (5, 6, 11, and 12). The discrepancy
between our results and those obtained with typically developing
participants underline the relevance of directly comparing
affected humans and mice to evaluate the validity of translational
paradigms in FXS.
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To provide practical advice regarding which conditions and
mazes should be used for extrapolating results from mice to
humans in translational research, we examined the overall
pattern of consistencies across the different measures and
identified those that provided at least two equivalent cross-
species comparisons. Irrespective of visual cues, Mazes 2, 4,
and 5 provided no or small species differences for at least
two measures of performance, suggesting that these conditions
have good potential to measure spatial learning/memory across
species. With regard to performance on the first trial, which
reflects visuo-spatial problem solving, Mazes 5 and 9 without
visual cues produced consistent results.
Notwithstanding the aforementioned cross-species
consistencies, many conditions failed to produce comparable
results in humans and mice, which highlights the need for
additional research focusing on the nature of the cognitive
processes implicated in this paradigm. This desideratum is not
merely theoretical but has very practical implications to clinical
researchers submitting their rationale and predictions about
variables that will change in drug trials to the drug regulatory
bodies (e.g., FDA in the United States). Specific outcomes have
not been scaled from mice to humans in recent trials such as the
trial of Arbaclofen in FXS, which was intended to improve social
avoidance (Berry-Kravis et al., 2017). One important obstacle to
demonstrating efficacy may have been the lack of a translational
measure validated on the basis of criteria such as those specified
in the present article. Within this context, it would be particularly
important to further investigate the purported dissociation
between the cognitive mechanisms underlying performance on
the first trial vs. improvements in performance across trials.
Indeed, there were no differences between FXS participants and
controls for performance on the first trial in MacLeod et al.
(2010). In contrast, deficits in spatial learning have been reported
using both the Hebb–Williams maze paradigm (MacLeod et al.,
2010) as well as other maze paradigms (e.g., radial maze: Mineur
et al., 2002; cross shaped maze: Dobkin et al., 2000). If our
findings of comparable and intact performance on the first
trial vs. comparable and impaired learning across trials were
corroborated, then it would support the utility of these two
measures to target distinct cognitive functions in drug efficacy
trials.
Finally, differences between mice and humans may have arisen
from the use of a virtual environment with humans. Indeed,
virtual navigation only assesses visually-based learning without
input from the other modalities recruited when participants
are actually moving through a real space (e.g., proprioception,
motor). Despite these differences, studies in the elderly generally
indicate that more often than not, results with virtual mazes
generalize to real maze paradigms (Moffat, 2009). Whether this
is also the case in individuals affected by FXS has yet to be
determined.
As whole, our results support the potential utility and validity
of the Hebb–Williams maze paradigm for measuring visual-
spatial abilities in translational research in FXS. First, it is the
only paradigm that has shown comparable patterns of results
in humans and mice using both the homology of impairments
approach (MacLeod et al., 2010) and the direct comparison
approach described here. Second, the paradigm measures visuo-
spatial problem solving as well as spatial learning and memory,
two processes that have been shown to be impacted by the
lack of FMRP and important targets for treatment (Cornish
et al., 1999). Third, while more work is needed in this area,
there is evidence that performance on the Hebb–Williams maze
paradigm can be examined and related at multiple levels of
analysis including cognitive and behavioral functioning (e.g.,
MacLeod et al., 2010), anatomical pathways (e.g., Hunsaker
et al., 2008), and molecular pathways (e.g., Gandhi et al.). In
light of these promising results, we feel that increased emphasis
needs to be directed toward specifying the practical parameters
for the Hebb–Williams paradigm as well as other paradigms
that allow direct comparison of humans and animals (e.g.,
object-discrimination learning and reversal, radial mazes, see
Boutet et al., 2007; Kogan et al., 2009; Gilmour et al., 2013;
McGonigle and Ruggeri, 2014; Gabel et al., 2016; see also Watase
and Zoghbi, 2003). These efforts are critically important to
extrapolating results of drug discovery as well as basic cellular
and molecular research from animal studies to humans and
therefore in ultimately improving the lives of those affected
by FXS.
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